Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
基本信息
- 批准号:10300992
- 负责人:
- 金额:$ 3.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-01 至 2022-01-02
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAnaphaseAndrogen ReceptorAutomobile DrivingBindingBiochemicalBiochemical GeneticsBiochemistryBiological AssayBiological ProcessCancer PatientCarcinomaCastrationCell DeathCell SurvivalCellsChemoresistanceChromatinChromosome abnormalityClinicalClinical ManagementComputer AnalysisCoupledCytogeneticsDataData SetDefectDevelopmentDiseaseDissectionEpigenetic ProcessEvaluationExperimental ModelsFutureGene ExpressionGene Expression ProfilingGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGenome StabilityGenomic approachGoalsHumanImmunohistochemistryImportinsIn VitroLaboratoriesLeadLinkMalignant NeoplasmsMalignant neoplasm of prostateMetastatic Prostate CancerMicroscopyMitosisMitoticMitotic ActivityMitotic CheckpointModelingMolecular TargetNuclear PoreNuclear Pore ComplexNuclear Pore Complex ProteinsOncogenicOrganoidsOutcomePathogenesisPathway interactionsPatient-Focused OutcomesPatientsPharmacologyPhosphotransferasesPlayPost-Translational Protein ProcessingPre-Clinical ModelProductionPropertyProstateProstatic NeoplasmsProtein IsoformsProteomicsPublishingReceptor SignalingRefractoryRefractory DiseaseRegulationResearch ProposalsResistanceResolutionRoleSamplingSolid NeoplasmTestingTherapeutic InterventionTissue SampleTranscriptional RegulationTumor TissueUp-RegulationValidationVariantWorkadvanced prostate canceraurora B kinaseclinical developmentclinical efficacyclinically relevantclinically significantcofactorcohortefficacy testingfunctional genomicsgenetic approachgenome integrityhigh resolution imaginghuman diseaseimprovedin vivoinhibitorinner centromere proteininnovationlive cell imagingmicroscopic imagingneoplastic cellnovelnovel markernovel therapeutic interventionnucleocytoplasmic transportpre-clinicalpredictive markerpreventprostate cancer cellprostate cancer modelprostate cancer progressionresponsetherapy resistanttranscription factortranscriptomicstumortumor progressiontumorigenesis
项目摘要
PROJECT SUMMARY
Advanced carcinomas are among the most lethal human diseases, being metastatic prostate cancer (PC) a
classic example. Despite current treatments, metastatic PC progresses to a therapy resistant stage that
precedes lethality. Therefore, there is a need to identify new targetable mechanisms driving cancer
aggressiveness to continue improving patients’ outcome. The main objective of this research proposal is to
dissect the mechanisms by which Nuclear Pore Complexes (NPCs) regulate genome functions (gene expression
and integrity) in PC and uncover novel NPC-regulated targetable pathways using innovative pre-clinical models
of lethal PC. NPCs contribute to different biological functions through their building blocks nucleoporins (Nups),
including nucleo-cytoplasmic transport, chromatin organization, gene expression, genome integrity and mitotic
regulation. In the context of cancer, Nups have been associated to tumor formation and development, however
their specific mechanistic role in cancer pathogenesis remains largely unknown. Recently we identified clinically
relevant Nups upregulated in lethal PC through interrogation of publicly available patient tissue sample
transcriptomic datasets containing primary and castration-chemotherapy-resistant metastatic prostate tumors.
Within the upregulated Nups, POM121 was shown to play a role in the aggressiveness of lethal PC (cell survival,
proliferation and tumorigenesis) via nuclear transport regulation. Yet, the specific transport-dependent and -
independent mechanisms by which POM121 regulates the aggressive features of PC and its crosstalk with other
Nups remain unknown. Notably, functional genomic studies (transcriptomic and computational analysis)
combined with biochemical and single-cell high-resolution imaging have revealed a crosstalk between two top
upregulated Nups in lethal PC, POM121 and TPR, which impacts on the aggressiveness properties of PC cells.
Specifically, we found that PC cell survival is enhanced by the POM121 transcriptional regulation of specific
genome stability genes and TPR, which in turn regulates mitotic checkpoint activity, through Androgen Receptor
(AR)-dependent and independent mechanisms. Crucially, our studies have also uncovered a potential novel role
of soluble chromatin-bound Nups in the regulation of aggressive features of PC cells potentially through direct
transcriptional regulation. Thus, collectively these results led to the hypothesis that NPCs regulate PC
aggressiveness through multifaceted mechanisms controlling both genome functions and stability. We will
address this hypothesis and determine the Nup-specific mechanisms contributing to PC aggressiveness through
three aims. In Aim 1, we will define POM121 nuclear transport-dependent and -independent mechanisms
promoting PC aggressiveness. In Aim 2, we will examine the POM121-TPR mechanistic interplay enhancing
genome stability and cell survival in lethal PC. In Aim 3, we will evaluate the clinical significance and efficacy of
targeting specific NPC-regulated pathways controlling genome integrity in patient derived pre-clinical models.
项目摘要
晚期癌是最致命的人类疾病之一,是转移性前列腺癌(PC)A
经典示例。尽管目前治疗,但转移性PC仍发展为抗治疗阶段
先于致命性。因此,有必要确定驱动癌症的新的目标机制
侵略性继续改善患者的结果。该研究建议的主要目的是
剖析核孔复合物(NPC)调节基因组功能的机制(基因表达
PC中的完整性),并使用创新的临床前模型发现了新型NPC调节的可定位途径
致命PC。 NPC通过其构建块核电蛋白(NUPS)促进不同的生物学功能,
包括核胞质转运,染色质组织,基因表达,基因组完整性和有丝分裂
规定。在癌症的背景下,NUP与肿瘤形成和发育有关,但是
它们在癌症发病机理中的特定机械作用在很大程度上仍然未知。最近我们在临床上确定了
通过询问公开可用的患者组织样本,在致命PC中更新了相关的NUPS
含有原发性和castatration-化学疗法的转移性前列腺肿瘤的转录组数据集。
在更新的NUP中,POM121被证明在致命PC的侵略性中起作用(细胞存活,
通过核转运调节的增殖和肿瘤发生)。但是,特定的运输依赖性和 -
POM121的独立机制调节PC的侵略性及其与其他的串扰
NUP仍然未知。值得注意的是,功能基因组研究(转录组和计算分析)
结合生化和单细胞的高分辨率成像,揭示了两个顶部之间的串扰
在致命PC,POM121和TPR中上调NUP,这会影响PC细胞的侵略性。
具体而言,我们发现POM121的转录调节提高了PC细胞的存活率
基因组稳定基因和TPR,进而调节有丝分裂检查点活性,通过雄激素受体
(AR)依赖性和独立机制。十足的是,我们的研究也发现了潜在的新作用
在调节PC细胞的侵略性特征的调节中可能通过直接的
转录调节。这些结果总的来说导致了NPC调节PC的假设
通过控制基因组功能和稳定性的多方面机制的侵略性。我们将
解决这一假设,并确定通过
三个目标。在AIM 1中,我们将定义POM121核转运依赖性和非依赖性机制
促进PC侵略性。在AIM 2中,我们将检查POM121-TPR机械相互作用增强
致命PC中的基因组稳定性和细胞存活。在AIM 3中,我们将评估临床意义和效率
针对特定的NPC调节的途径,该途径控制患者衍生的临床前模型中的基因组完整性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Veronica Rodriguez-Bravo其他文献
Veronica Rodriguez-Bravo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Veronica Rodriguez-Bravo', 18)}}的其他基金
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10532741 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10558020 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Role of nuclear pore-regulated mechanisms in prostate cancer aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10272909 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10059202 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
Genome Stability Regulation by the Nuclear Pore-Chromosome Axis and Defects in Tumor Cells
核孔染色体轴的基因组稳定性调节和肿瘤细胞的缺陷
- 批准号:
9626618 - 财政年份:2016
- 资助金额:
$ 3.04万 - 项目类别:
Genome Stability Regulation by the Nuclear Pore-Chromosome Axis and Defects in Tumor Cells
核孔染色体轴的基因组稳定性调节和肿瘤细胞的缺陷
- 批准号:
9162317 - 财政年份:2016
- 资助金额:
$ 3.04万 - 项目类别:
Genome Stability Regulation by the Nuclear Pore-Chromosome Axis and Defects in Tumor Cells
核孔染色体轴的基因组稳定性调节和肿瘤细胞的缺陷
- 批准号:
9330819 - 财政年份:2016
- 资助金额:
$ 3.04万 - 项目类别:
相似国自然基金
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
- 批准号:32100463
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
- 批准号:21922410
- 批准年份:2019
- 资助金额:120 万元
- 项目类别:优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
- 批准号:81402157
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10532741 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10558020 - 财政年份:2022
- 资助金额:
$ 3.04万 - 项目类别:
Signaling Mechanisms that Control Chromosome Segregation during Female Meiosis
女性减数分裂过程中控制染色体分离的信号机制
- 批准号:
10332058 - 财政年份:2020
- 资助金额:
$ 3.04万 - 项目类别:
Role of nuclear pore-regulated mechanisms in prostate cancer aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10272909 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
核孔调节机制在前列腺癌侵袭性中的作用
- 批准号:
10059202 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别: